GSK US news
GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news.
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a pivotal phase III study, LATITUDE-TIMI 60, to evaluate the effects of losmapimod in patients presenting with acute coronary syndrome.
Posted: June 5, 2014, 4:54 pm
Posted: June 4, 2014, 5:15 pm
Posted: June 2, 2014, 7:30 pm
Posted: June 1, 2014, 7:30 am
Posted: May 27, 2014, 8:00 pm
Posted: May 23, 2014, 4:00 pm
GSK announced the submission of a regulatory application to the Japanese MHLW for UMEC a LAMA, administered using the Ellipta™ dry powder inhaler.
Posted: May 23, 2014, 8:00 am
GSK announced today that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support.
Posted: May 20, 2014, 9:00 am
GSK announced today that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support.
Posted: May 20, 2014, 5:30 am